H. Lundbeck AS (LTS:0ND5) Other Stockholders Equity : kr1,285 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is H. Lundbeck AS Other Stockholders Equity?

H. Lundbeck AS's Other Stockholders Equity for the quarter that ended in Mar. 2024 was kr1,285 Mil.

H. Lundbeck AS's quarterly Other Stockholders Equity declined from Sep. 2023 (kr1,556 Mil) to Dec. 2023 (kr1,172 Mil) but then increased from Dec. 2023 (kr1,172 Mil) to Mar. 2024 (kr1,285 Mil).

H. Lundbeck AS's annual Other Stockholders Equity increased from Dec. 2021 (kr712 Mil) to Dec. 2022 (kr1,594 Mil) but then declined from Dec. 2022 (kr1,594 Mil) to Dec. 2023 (kr1,172 Mil).

H. Lundbeck AS Other Stockholders Equity Historical Data

The historical data trend for H. Lundbeck AS's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

H. Lundbeck AS Other Stockholders Equity Chart

H. Lundbeck AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

807.00

229.00

712.00

1,594.00

1,172.00

H. Lundbeck AS Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Stockholders Equity	Get a 7-Day Free Trial															1,526.00	1,507.00	1,556.00	1,172.00	1,285.00

H. Lundbeck AS Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

H. Lundbeck AS Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of H. Lundbeck AS's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

H. Lundbeck AS (LTS:0ND5) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » H. Lundbeck AS (LTS:0ND5) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

HLBBF:USA HLUBF:USA 0ABR:UK HLUN A:Denmark HLUN B:Denmark LDBA:Germany

Address

Ottiliavej 9, Valby, DNK, 2500

Website

https://www.lundbeck.com

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system, or CNS, drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

H. Lundbeck AS (LTS:0ND5) Headlines

No Headlines